Separated registration system premature to implement soon.

The domestic pharmaceutical manufacturers group expressed an opposing attitude against the impending government movement of revising the current Pharmaceutical Affairs Act, key subjects of which are now under the process of the public hearing, claiming that the separated registration system for the manufacturing business and products might seriously discourage the industry.

The group indica...